AI inroads in ophthalmology
This article focused on opportunities to leverage AI to streamline ophthalmology practices.
Comments Off on AI inroads in ophthalmology
December 4, 2023
All articles from EyeWorld.org on the topic of artificial intelligence. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
EyeWorld Weekly, November 3, 2023
➤ FDA expands eye drop warning list ➤ Positive results in Phase 2a trial for new biodegradable sustained drug delivery implant ➤ Phase 2b study begins for investigational therapy for acute infectious conjunctivitis ➤ FDA approves additional treatment indication for bispecific antibody ➤ Enrollment complete for study evaluating femtosecond laser-created trabeculotomy ➤ Company to study personalized medicine for patients with wet AMD ➤ Enrollment complete for Phase 2b trial evaluating wet AMD therapy ➤ Pivotal trial for wet AMD therapy begins ➤ Survey evaluates female ophthalmologist experiences ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, November 3, 2023
November 3, 2023
EyeWorld Weekly, September 22, 2023
➤ First AI foundation model in ophthalmology ➤ 24-month topline data from Phase 3 geographic atrophy therapy ➤ Positive data from Phase 1/2 trial for retinitis pigmentosa, Leber congenital amaurosis treatment ➤ FDA clearance granted for portable retinal imaging system ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, September 22, 2023
September 22, 2023
EyeWorld Weekly, June 2, 2023
➤ Phase 2 trial with experimental geographic atrophy treatment shows preservation of visual function ➤ AI-enabled screening system receives FDA clearance ➤ Enrollment complete for study evaluating investigational first-line therapy for DME ➤ Updates from two retinitis pigmentosa trials ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, June 2, 2023
June 2, 2023
DOS 1 year later
EyeWorld had a conversation with Eric Rosenberg, DO, and John Kitchens, MD, about the Digital Ophthalmic Society (DOS), which they co-founded and launched in April 2022. The discussion covered what DOS is and digital innovation in ophthalmology.
Comments Off on DOS 1 year later
May 10, 2023
EyeWorld Weekly, June 10, 2022
➤ FDA approves brolucizumab injection for DME ➤ NDA filed for geographic atrophy drug ➤ Study: Dietary supplements can slow AMD progression ➤ First global study evaluates AI for diabetic retinopathy and referral uptake ➤ Plans to begin two Phase 3 trials for investigational thyroid eye disease therapy ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, June 10, 2022
June 10, 2022
EyeWorld Weekly, June 3, 2022
➤ Machine assesses cardiovascular risk with retinal scan ➤ FDA requests more info for BLA for bevacizumab ➤ Genetic variables affect NMOSD treatment ➤ Study: 12-month results from canaloplasty-trabeculotomy procedure ➤ Topline results from Phase 3 pivotal trial evaluating pupil-modulating drug ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, June 3, 2022
June 3, 2022
EyeWorld Weekly, January 15, 2021
➤ Success with first-in-human implant of new artificial cornea ➤ Launch of first longitudinal study for home OCT ➤ Enrollment complete for study evaluating treatment for Leber congenital amaurosis 10 ➤ Phase 1/2a trial for wet AMD treatment with suprachoroidal injection begins enrollment ➤ Fast Track designation issued for investigational dry AMD therapy
Comments Off on EyeWorld Weekly, January 15, 2021
January 15, 2021
EyeWorld Weekly, January 8, 2021
➤ Commercial launch of Alcon’s Vivity IOL ➤ Topline results from Phase 2 trial for treatment of contact lens discomfort ➤ Company registers new artificial intelligence visual field exam device with FDA ➤ Positive Phase 3 results for faricimab for DME ➤ Research begins to create a MIGS patient-reported outcomes instrument ➤ ASCRS events
Comments Off on EyeWorld Weekly, January 8, 2021
January 8, 2021